5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...

5/15/2025Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...

5/14/2025Beigene Submits New Indication Application for BCL2 Inhibitor Sonrotoc...

5/14/2025CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...

5/14/2025RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...

5/14/2025Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...

5/14/2025BRL Medicine's Allogeneic CAR-T Therapy Shows Promising Results in Ref...

5/14/2025NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M

5/12/2025CARsgen Reports Encouraging Early Data for Allogeneic BCMA CAR-T CT059...

5/12/2025CureGene Unveils Potent Liver-Targeted THR-β Prodrug CG-0416 with Pro...

5/12/2025AusperBio Reports Promising Phase IIb Results for AHB-137 in Chronic H...

5/12/2025Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...

5/7/2025Roche's Columvi Wins Expanded Approval in China for 2L+ DLBCL

5/7/2025Everest Medicines Announces NMPA Full Approval of NEFECON

5/7/2025Early Clinical Data from China Show Promise for In Vivo CAR-T Therapie...

5/6/2025Immunochina’s IM96 CAR-T Cell Therapy Wins FDA IND Clearance

5/6/2025China Approves Six Novel Drugs in April 2025, Marking Significant Adva...

5/6/2025Kintor Reports Superior Hair Regrowth Results for KX-826 and Minoxidil...

5/6/2025CStone Unveils Promising Preclinical Data for Trispecific Antibody CS2...

Page:22/22 Total number of articles:649: [First][<<] [18] [19] [20] [21] [22] [>>] [End]